The conference is sponsored by the Alzheimer's Drug Discovery Foundation (www.alzdiscovery.org ) and its primary objective is to advance drug discovery for neurodegenerative diseases by educating attendees on the process of translational research. Lectures and case studies on Alzheimer's disease, Parkinson's disease, ALS, MS and Huntington's disease will be presented.
The 2-day event is targeted towards academic and industry scientists, business development and licensing professionals, and investors.
More information regarding the conference may be found at www.worldeventsforum.com/addf/2010/ 
Email: meetings [ at ] worldeventsforum [dot] com